Early Oral Feeding in Gastresophageal Tumors Surgery

A Randomized Controlled Trial evaluating the Efficacy of Early Postoperative Oral Feeding in Patients with Gastresophageal Tumors Undergoing Surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201204122982N8

Enrollment

138

Registered

2012-10-16

Start date

2011-11-03

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Gastric Tumor. Condition 2: Cardiac Tumor. Condition 3: Esophageal Cancer. Malignant neoplasm of stomach Malignant neoplasm of cardia Malignant neoplasm of esophagus

Interventions

Intervention 1: On the basis of the protocol, in patients of early oral feeding group (referred to as Case group) a liquid regimen was started in 24 to 48 hours after the surgery. The regimen containe

Rehabilitation

On the basis of the protocol, in patients of early oral feeding group (referred to as Case group) a liquid regimen was started in 24 to 48 hours after the surgery. The regimen contained 50 cc tea comb

In traditional oral feeding group referred to as Control group, oral feeding was started following five postoperative days in case of either audible bowel sounds, passage of flatus or bowel habits.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Malignancy of Esophagus and Stomach, Major surgery for patient management, and agreement to enter the study. Exclusion Criteria: Expiration within early postoperative period, proved preoperative infection, history of pelvic or abdominal radiation, already on immunosupressive agents.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Vomiting. Timepoint: Everyday. Method of measurement: Asking the patient.;Soft Diet. Timepoint: Days tolerated. Method of measurement: Asking the patient.;Length of Administration > 1000cc Serum daily. Timepoint: Everyday. Method of measurement: Patient's Medical Records.	—

Secondary

Measure	Time frame
Hospital Stay. Timepoint: At Discharge. Method of measurement: Patient's Medical Records.;Postoperative Complication. Timepoint: Everyday. Method of measurement: Examination, History and Medical Records.;Re-hospitalization. Timepoint: After Discharge. Method of measurement: Medical Records.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZhamak Khorgami

Tehran University of Medical Sciences

khorgami@gmail.com+98 21 8490 2450

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026